GYRE THERAPEUTICS

Serial Number 99248258
641

Registration Progress

Application Filed
Jun 23, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action E-Mailed
Due: Feb 19, 2026 64 days

Trademark Image

GYRE THERAPEUTICS

Basic Information

Serial Number
99248258
Filing Date
June 23, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
641
Status Date
Nov 19, 2025
Application
Pending
Classes
005 042

Rights Holder

Gyre Therapeutics, Inc.

03
Address
12770 High Bluff Drive, Suite 150
San Diego, CA 92130

Ownership History

Gyre Therapeutics, Inc.

Original Applicant
03
San Diego, CA

Legal Representation

Attorney
Khanh T. Glatzel

USPTO Deadlines

Next Deadline
64 days remaining
Non-Final Action E-Mailed
Due Date
February 19, 2026
Extension Available
Until May 19, 2026

Application History

8 events
Date Code Type Description Documents
Nov 19, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 19, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 19, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 12, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 30, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 30, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 23, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 23, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of chronic obstructive pulmonary disease, pulmonary arterial hypertension, acute liver failure, acute-on-chronic liver failure, liver fibrosis, metabolic dysfunction associated fatty liver disease, nonalcoholic steatohepatitis, idiopathic pulmonary fibrosis, lung fibrosis, organ fibrosis, and inflammatory diseases
Class 042
Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Testing of pharmaceuticals
First Use Anywhere: Oct 30, 2023
First Use in Commerce: Oct 30, 2023

Additional Information

Design Mark
The mark consists of five crescent shapes arranged to form a circle, a capsule shape resembling a pill inside the circle, the capsule having a half crescent shape cutting into the capsule, letters forming the phrase “Gyre” with the letter “G” in capital letter situated to the right of the circle, and letters forming the phrase “THERAPEUTICS” situated underneath the phrase “Gyre”.

Classification

International Classes
005 042